1Drop Diagnostics CEO Luc Gervais holding a diagnostic chip.
The article in Bilan features our portable diagnostic device that detects biomarkers specific to certain pathologies such as heart attacks, cancers or infections, from a single drop of blood deposited on a microfluidic chip.
The product meets strong trends in eHealth. “Diagnostic tools were until recently the preserve of analytical laboratories. With the development of compact and affordable devices that guarantee a high level of performance, medical practitioners and pharmacists are increasingly equipped with the technology to take charge of this stage of patient care themselves” says Luc Gervais, founder and CEO of 1Drop Diagnostics. The system foresees that results of analyses will be transmitted directly to the doctor or even to the patient on a smartphone.
You can find the full article here.